EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access

Systematic review and meta-analysis of segmentectomy vs. lobectomy for stage IA non-small cell lung cancer

Zhangyi Dai, Jiawen Hu, Cheng Shen, Xingqi Mi, Qiang Pu

Journal of Thoracic Disease · 2023-08 · 15 (8) · 4292-4305

DOI: 10.21037/jtd-23-410 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Thoracic Disease, 2023-08. Verfasst von Zhangyi Dai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Sichuan University West China Medical Center, Chengdu, China. Die Arbeit wurde bisher 19-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Whether segmentectomy is appropriate for stage IA non-small cell lung cancer (NSCLC), especially for stage IA NSCLC with a tumor size of 2-3 cm, remains controversial. Thus, we conducted this meta-analysis to compare segmentectomy and lobectomy for stage IA NSCLC with a tumor size of 2-3 cm and IA ≤2 cm NSCLC.

Methods

A systematic screening of online databases (PubMed, Embase, Web of Science, and Cochrane Library) was conducted regarding the terms of perioperative outcomes, overall survival (OS), recurrence-free survival (RFS), and disease-free survival (DFS). The inverse-variance and Mantel-Haenszel approaches were used to pool effect sizes for survival outcomes and perioperative outcomes.

Results

A total of 10 articles were included in the analysis. The perioperative morbidity [risk ratio (RR): 0.90, P=0.10], mortality (RR: 0.94, P=0.84), intraoperative blood loss [mean difference (MD): 3.07, P=0.86] and operative time (MD: 18.99, P=0.13) were comparable between the segmentectomy and lobectomy groups. The number of lymph nodes harvested was statistically less in segmentectomy than in lobectomy (MD: -5.71, P=0.02). In stage IA patients with a tumor size of 2-3 cm, lobectomy showed superior survival outcomes compared to segmentectomy, with a pooled hazard ratio (HR) of 1.39 (P=0.01) for OS and 1.38 (P=0.06) for RFS or DFS. In stage IA ≤2 cm, lobectomy and segmentectomy had comparable survival outcomes with pooled HRs of 1.18 (P=0.29) for OS and 1.18 (P=0.12) for RFS or DFS.

Conclusions

When a patient is in stage IA and the tumor size is less than 2 cm, segmentectomy should be performed. If the tumor size is between 2 and 3 cm, lobectomy is recommended.

Schlagwörter

Stichwörter der Autor:innen

Non-small cell lung cancer (NSCLC)lobectomyrecurrence and survivalsegmentectomy

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Sichuan University West China Medical Center, Chengdu, China.
  • Operating Room, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.

Zitieren

APA

Dai, Z., Hu, J., Shen, C., Mi, X., & Pu, Q. (2023). Systematic review and meta-analysis of segmentectomy vs. lobectomy for stage IA non-small cell lung cancer. Journal of Thoracic Disease, 15(8), 4292-4305. https://doi.org/10.21037/jtd-23-410

Vancouver

Dai Z, Hu J, Shen C, Mi X, Pu Q. Systematic review and meta-analysis of segmentectomy vs. lobectomy for stage IA non-small cell lung cancer. Journal of Thoracic Disease. 2023;15(8):4292-4305. doi:10.21037/jtd-23-410

BibTeX
@article{Dai2023,
  author = {Dai, Zhangyi and Hu, Jiawen and Shen, Cheng and Mi, Xingqi and Pu, Qiang},
  title = {Systematic review and meta-analysis of segmentectomy vs. lobectomy for stage IA non-small cell lung cancer},
  journal = {Journal of Thoracic Disease},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {4292--4305},
  doi = {10.21037/jtd-23-410}
}
Kostenlos starten →